Home › Funds › Cormorant Asset Management, LP › MBX
Cormorant Asset Management, LP position in MBX
MBX BIOSCIENCES INC · Health Care
Cormorant Asset Management, LP reported holding 375,000 shares of MBX (MBX BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$22.0M, representing 1.57% of its reported portfolio and ranking #20 among its reported holdings. Cormorant Asset Management, LP has disclosed MBX holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Cormorant Asset Management, LP's MBX position evolved
Cormorant Asset Management, LP first disclosed a stake in MBX in Q3 2024 at 700,000 shares (US$18.2M). The position peaked in Q4 2025 at 1,120,000 shares, worth US$35.3M. Across 9 filings, Cormorant Asset Management, LP increased the stake 1 time(s), trimmed it 3 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 375,000 shares valued at US$22.0M — a reduction of -175,000 shares quarter over quarter.. Notable position changes include a 75% increase in Q3 2025 (shares rose 80% over the following quarter), a 51% trim in Q2 2026 (shares rose 6% over the following quarter), a 32% trim in Q3 2026 (shares fell 9% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 700.00K | $18.19M | New |
| Q4 2024 | 700.00K | $12.90M | Hold |
| Q1 2025 | 700.00K | $5.17M | Hold |
| Q2 2025 | 700.00K | $7.99M | Hold |
| Q3 2025 | 1.23M | $21.44M | Add |
| Q4 2025 | 1.12M | $35.32M | Reduce |
| Q1 2026 | 1.12M | $33.43M | Hold |
| Q2 2026 | 550.00K | $30.36M | Reduce |
| Q3 2026 | 375.00K | $21.98M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MBX and 13F data
MBX (MBX BIOSCIENCES INC) is a Health Care company. 57 other funds we track also report a position in MBX — the largest reported positions include Frazier Life Sciences Management, L.P. (US$389.9M), Paradigm Biocapital Advisors LP (US$221.2M), NEA Management Company, LLC (US$211.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MBX
- Frazier Life Sciences Management, L.P. 6.65M sh · $389.94M · Q3 2026
- Paradigm Biocapital Advisors LP 3.77M sh · $221.17M · Q3 2026
- NEA Management Company, LLC 3.61M sh · $211.88M · Q3 2026
- ORBIMED ADVISORS LLC 3.07M sh · $180.25M · Q3 2026
- NVP Associates, LLC 2.14M sh · $125.23M · Q3 2026
- Aaron Wealth Advisors LLC 1.18M sh · $68.92M · Q3 2026
- Kynam Capital Management, LP 934.80K sh · $54.80M · Q3 2026
- EVENTIDE ASSET MANAGEMENT, LLC 873.49K sh · $51.20M · Q3 2026
- Parkman Healthcare Partners LLC 716.54K sh · $42.00M · Q3 2026
- TCG Crossover Management, LLC 650.00K sh · $38.10M · Q3 2026
- Deep Track Capital, LP 640.00K sh · $37.52M · Q3 2026
- BRAIDWELL LP 398.95K sh · $23.39M · Q3 2026
More on Cormorant Asset Management, LP
FAQ
How long has Cormorant Asset Management, LP held MBX?
Cormorant Asset Management, LP has disclosed MBX holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
What is Cormorant Asset Management, LP's current position in MBX?
As of Q3 2026, Cormorant Asset Management, LP holds 375.00K shares of MBX (MBX BIOSCIENCES INC), valued at $21.98M, representing 1.57% of its reported portfolio and ranking #20.
Has Cormorant Asset Management, LP been buying or selling MBX?
In the latest 13F filing (Q3 2026), Cormorant Asset Management, LP reduced its position in MBX. The position peaked in Q4 2025 at 1.12M shares.
Which other funds hold MBX?
Other major institutional holders of MBX include Frazier Life Sciences Management, L.P., Paradigm Biocapital Advisors LP, NEA Management Company, LLC, among 57 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.